Kiniksa Pharmaceuticals, Ltd. (KNSA)
NASDAQ: KNSA · IEX Real-Time Price · USD
21.23
+0.07 (0.33%)
Jul 19, 2024, 4:00 PM EDT - Market open
Kiniksa Pharmaceuticals Analyst Ratings
Total Analysts
5
Consensus Rating
Strong Buy
Price Target
$30.20
Upside
+42.25%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy Initiates $34 | Buy | Initiates | $34 | +60.15% | May 3, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $26 → $30 | Buy | Maintains | $26 → $30 | +41.31% | May 1, 2024 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $25 → $30 | Buy | Maintains | $25 → $30 | +41.31% | Apr 24, 2024 |
| Wedbush | Wedbush | Buy Maintains $23 → $25 | Buy | Maintains | $23 → $25 | +17.76% | Jan 2, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $22 → $32 | Strong Buy | Maintains | $22 → $32 | +50.73% | Jul 26, 2023 |
| JP Morgan | JP Morgan | Buy Maintains $19 → $20 | Buy | Maintains | $19 → $20 | -5.79% | Mar 9, 2023 |
| B of A Securities | B of A Securities | Strong Buy Maintains $37 → $34 | Strong Buy | Maintains | $37 → $34 | +60.15% | Dec 29, 2021 |
| B of A Securities | B of A Securities | Strong Buy Initiates n/a | Strong Buy | Initiates | n/a | n/a | Apr 1, 2020 |
| JMP Securities | JMP Securities | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Sep 17, 2018 |